RecruitingNCT06577805

The Outcomes of Living Donor Robotic Assisted Kidney Transplantation

A Retrospective Cohort Study of Prospectively Collect the Outcomes of Recipients After Robot-assisted Kidney Transplantation


Sponsor

West China Hospital

Enrollment

400 participants

Start Date

Jul 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria2

  • living-donor kidney transplant recipients
  • receiving standard triad immunosuppressive regimen

Exclusion Criteria4

  • active infection
  • multi-organ transplantation
  • malignancy history in the donor and recipient
  • human immunodeficiency virus infection

Locations(1)

West China Hospital, Sichuan University

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06577805


Related Trials